Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial

BACKGROUND: A high-dose proton pump inhibitor (PPI)-amoxicillin dual therapy has been investigated for treatment of patients with Helicobacter pylori (H. pylori) infection. Currently, the efficacy of this dual therapy remains inconclusive, with controversial findings from various single-center clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Hao, Guo, Yan, Zhao, Jing-Tao, Yang, Jun, Sun, Wen-jing, Zhang, De-kui, He, Ping, Shi, Gang, Su, Na-yun, Han, Ran, Lan, Chun-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Helicobacter pylori Infection — pathogenesis, management and prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806404/
https://www.ncbi.nlm.nih.gov/pubmed/36600686
http://dx.doi.org/10.1177/17562848221142925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806404/
https://www.ncbi.nlm.nih.gov/pubmed/36600686
http://dx.doi.org/10.1177/17562848221142925

Ejemplares similares